SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
___________
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
|
Date
of report (Date of earliest event reported)
|
June
22, 2010
|
|
VARIAN
MEDICAL SYSTEMS, INC.
|
|
(Exact
Name of Registrant as Specified in its
Charter)
|
|
Delaware
|
1-7598
|
94-2359345
|
|
(State
or Other Jurisdiction
of
Incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
|
3100
Hansen Way, Palo Alto, CA
|
94304-1030
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
|
Registrant's
telephone number, including area code
|
(650)
493-4000
|
|
Not
Applicable
|
|
(Former
Name or Former Address, if Changed Since Last
Report)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
¨ Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
7.01.
|
Regulation FD
Disclosure
|
At a June
22, 2010 event, Scripps Health announced that it will be developing the Scripps
Proton Therapy Center in San Diego, California (the “Scripps Center”) with
partners including Advanced Particle Therapy LLC and Varian Medical Systems,
Inc. (“Varian”). Varian has entered into a purchase agreement valued
at $88 million to supply Varian’s particle therapy system for the planned
Scripps Center. The agreement is subject to a contingency that financing
for the Scripps Center be complete, and Varian will not book the order for this
system until such financing is complete. The Scripps Center will be
operated by Scripps Health under the medical direction of the Scripps Clinic
Medical Group.
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| Varian Medical Systems, Inc. | |||
|
By:
|
/s/ JOHN W. KUO | ||
| Name: | John W. Kuo | ||
|
Title:
|
Corporate
Vice President, General Counsel and Secretary
|
||
Dated: June
22, 2010
3